Thermo Fisher Scientific (TMO)
Sector: | Health Care |
Super Investor Stats: | |
Ownership count: | 9 |
Ownership rank: | 34 |
% of all portfolios: | 0.238% |
Hold Price * : | $547.33 |
Total insider Buys/Sells last 6 months: |
| Transactions | Total |
Buys |
0 |
$0 |
Sells |
78 |
$74,713,278 |
|
Portfolio Manager |
% of portfolio |
Recent activity |
Shares |
Value |
≡ |
Wallace Weitz - Weitz Large Cap Equity Fund |
4.78 |
|
75,000 |
43,591,000 |
≡ |
Chris Hohn - TCI Fund Management |
4.64 |
Reduce 1.47% |
3,146,382 |
1,670,068,000 |
≡ |
William Von Mueffling - Cantillon Capital Management |
3.13 |
Reduce 2.41% |
882,017 |
468,166,000 |
≡ |
Polen Capital Management |
2.60 |
Reduce 5.49% |
2,032,950 |
1,079,160,000 |
≡ |
David Katz - Matrix Asset Advisors |
1.46 |
Reduce 4.35% |
21,011 |
12,212,000 |
≡ |
AKO Capital |
1.24 |
Reduce 51.56% |
163,937 |
87,016,000 |
≡ |
Viking Global Investors |
1.05 |
Reduce 40.15% |
538,485 |
285,822,000 |
≡ |
Thomas Gayner - Markel Asset Management |
0.11 |
Add 44.12% |
19,600 |
10,403,000 |
≡ |
Lee Ainslie - Maverick Capital |
0.02 |
Add 94.25% |
1,521 |
807,000 |
Open Market Insider Buys
Date Filed |
Reporting Name |
Relationship |
Trans. Date |
Shares |
Price $ |
Total Value $ |
06 Oct 2023 |
BOXER MICHAEL A |
SVP and General Counsel |
26 Jun 2023 |
4 |
526.15 |
2,105 |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.
P = Preferred Stock